LISA DEISCH: Open Payments
NPI 1316653892 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,501 in 123 payments from 33 companies in 2025. Trend: 2023 $79 · 2024 $2,116 · 2025 $2,501
Food & beverage: $2,501
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $151 |
| Alexion Pharmaceuticals, Inc. | 7 | $148 |
| Biogen, Inc. | 7 | $147 |
| SK Life Science, Inc. | 6 | $146 |
| Lundbeck LLC | 5 | $135 |
| UCB, Inc. | 5 | $133 |
| Neurocrine BioSciences, Inc. | 6 | $133 |
| Aucta Pharmaceuticals, Inc. | 8 | $104 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| Octapharma USA, Inc. | 2 | $97 |
Products named: KESIMPTA, ULTOMIRIS, VYEPTI, INGREZZA, TYSABRI, Motpoly XR, PANZYGA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
